Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Episurf Medical AB (publ)    EPIS B   SE0003491562

EPISURF MEDICAL AB (PUBL)

(EPIS B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Episurf Medical : Upping Long-Term Sales

09/25/2020 | 02:01am EST

Redeye strengthens its confidence in the Episurf equity story, following the Capital Markets Day held last week. We have revised our long-term sales and are now closer aligned with the management’s targets. However, we want to see further clinical evidence and the first mark on top-line before we feel entitled to raise our estimates even further. Nonetheless, our revised estimates have a positive impact on all our fair values.

Read more and download the Research Update

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases

All news about EPISURF MEDICAL AB (PUBL)
11/30EPISURF MEDICAL : Episealer® presentation at the Combined Bristol & Oxford Unico..
AQ
11/27EPISURF MEDICAL : enters into international advisory agreement
AQ
11/26EPISURF MEDICAL : carries out a directed share issue and raises proceeds of SEK ..
AQ
11/13EPISURF MEDICAL : First Episealer® surgery in Scotland performed
AQ
11/04EPISURF MEDICAL : First Episealer® Talus surgery in Scandinavia performed
AQ
10/26DNB MARKETS - EPISURF MEDICAL :  Clinical data strengthens the case
AQ
10/26EPISURF MEDICAL : First Episealer® surgery performed in Asia
AQ
10/23EPISURF MEDICAL : Interim Report 1 July - 30 September 2020
AQ
10/15EPISURF MEDICAL : enters into a distribution agreement for additional markets in..
AQ
10/14EPISURF MEDICAL : Members of the Nomination Committee for Episurf Medical's Annu..
AQ
More news
Financials
Sales 2020 6,00 M 0,71 M 0,71 M
Net income 2020 -72,8 M -8,63 M -8,63 M
Net cash 2020 81,0 M 9,61 M 9,61 M
P/E ratio 2020 -5,67x
Yield 2020 -
Capitalization 419 M 49,6 M 49,7 M
EV / Sales 2020 56,4x
EV / Sales 2021 35,2x
Nbr of Employees 25
Free-Float 89,1%
Chart EPISURF MEDICAL AB (PUBL)
Duration : Period :
Episurf Medical AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EPISURF MEDICAL AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 2
Average target price 4,00 SEK
Last Close Price 2,27 SEK
Spread / Highest target 76,6%
Spread / Average Target 76,6%
Spread / Lowest Target 76,6%
EPS Revisions
Managers
NameTitle
Pål Ryfors Chief Executive Officer
Dennis D. Stripe Chairman
Katarina Flodstrom Chief Operating & Regulatory Officer
Veronica Wallin Chief Financial Officer
Leif Erik Sigfrid Ryd Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EPISURF MEDICAL AB (PUBL)93.59%50
STRYKER CORPORATION11.83%88 228
SMITH & NEPHEW PLC-18.61%17 609
INSPIRE MEDICAL SYSTEMS, INC.160.88%5 215
VENUS MEDTECH (HANGZHOU) INC.99.33%4 079
GLAUKOS CORPORATION30.11%3 184